Hogan Lovells advises EyePoint on its US$150 million follow-on public offering of equity securities
EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT) has received advice from Hogan Lovells on its US$150 million follow-on public offering of common stock shares and pre-funded warrants to buy common stock.